Skip to main content

InvestorNewsBreaks – Hero Technologies (HENC) Submits Application for OTCQB Trading; Looks to Strengthen Investor Relations

Hero Technologies (OTC: HENC), an early-stage cannabis company focused on a vertically integrated business model, announced that it has applied to list its common stock on the OTC Markets Group. The company is looking to list the stock on the OTCQB marketplace, which is the mid-tier OTC equity market for U.S. stocks and is designed for early-stage developing companies. According to the announcement, in order to qualify for the marketplace, HENC must meet reporting standards, undergo annual verification and certification, meet a $0.01 bid test, and have a public float in excess of 10% of the total shares outstanding; the company must also have a minimum of 50 beneficial shareholders who each own at least 100 shares. In submitting its application, Hero Technologies noted it was committed to those standards. “As we continue reporting on the progress of our company and engage in marketing and stock awareness campaigns, it is essential that our shareholders and other investors understand that we are committed to sharing information transparently,” said Hero Technologies CEO Gina Serkasevich in the press release. “We fully embrace our obligation as a public company to provide accurate, timely disclosures of any information that could affect the trading market for our common stock. . . . For example, we will keep investors closely aware of further developments in the Michigan cannabis market, where our subsidiary, BlackBox Systems and Technologies LLC, has received prequalification approval for a license to produce both recreational and medicinal cannabis.”

To view the full press release, visit https://ibn.fm/492bv

About Hero Technologies Inc.

Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. The company’s strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multistate operator (“MSO”). For more information about the company, please visit www.HeroTechnologiesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://ibn.fm/HENC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.